Journal article
Prospective open-label study of the administration of two-percent voriconazole eye drops
D Al-Badriyeh, L Leung, T Roydhouse, R Fullinfaw, M Daniell, GE Davies, K Stewart, DCM Kong
Antimicrobial Agents and Chemotherapy | Published : 2009
DOI: 10.1128/AAC.01700-08
Abstract
Thirteen human subjects scheduled for elective anterior segment eye surgery received hourly 2% voriconazole eye drops 4 hours presurgery. No side effects were reported. Significantly, the voriconazole concentration in the aqueous humor of the eye was similar to that reported for the 1% voriconazole solution, suggestive of concentration-independent absorption. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Grants
Funding Acknowledgements
This study was funded by a research grant from the RVEEH (VIC, Australia).